INTRODUCING TEMPUS NEXT: AI-ENABLED CARE PATHWAY INTELLIGENCE /// EXPLORE NOW INTRODUCING TEMPUS NEXT: AI-ENABLED CARE PATHWAY INTELLIGENCE ///
12/04/2020

Ongoing Partial Response at 6 Months to Olaparib for Metastatic Melanoma With Somatic PALB2 Mutation After Failure of Immunotherapy: A Case Report

Annals of Oncology Manuscript
Authors B. Lau, A.M. Menzies, A.M. Joshua

A 75-year-old man presented with progressive aphasia. Past medical history included two resected primary cutaneous melanomas of shoulder and forearm, transient ischaemic attacks, non-insulin-dependent diabetes, hypertension, and radical prostatectomy at age 67 years. Family history revealed bowel cancer in the father and ovarian cancer in the daughter, diagnosed at age mid-80s and mid-40s, respectively…

VIEW THE PUBLICATION